Examples of FDA-approved antibody-drug conjugates (ADCs) include Enhertu (trastuzumab deruxtecan) for HER2-positive cancers, Adcetris (brentuximab vedotin) for certain lymphomas, Kadcyla (ado-trastuzumab emtansine) for HER2-positive breast cancer, Padcev (enfortumab vedotin) for urothelial cancer, and Trodelvy (sacituzumab govitecan) for breast and urothelial cancers. These therapies use a targeted antibody to deliver a powerful anti-cancer drug (payload) directly to tumor cells, minimizing damage to healthy tissue."
____
With LL's also anti-tumor = positive affect also on ADC's.

ICI/ADC & verifying if killing Glioblastoma via blood circulation...

Wow the potential we're looking @ !!...Wow !!